Biotech stocks had a bad week after turmoil at the FDA, continuing a long period of underperformance after the pandemic. Many ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

These names in the biotech sector are seeing a substantial ... The company’s programs address significant unmet needs in GI health and include: latiglutenase, potentially first-in-class ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

Biotech companies make some of the best growth stocks. These firms are at the forefront of medical advances such as gene editing, immunotherapy, artificial intelligence (AI)-driven drug discovery, and ...

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...

In my view, there's little reason to think the biotech can pull it off, so it's not worth investing in the stock. The Motley Fool Stock Advisor analyst team just identified what they believe are ...

It was a busy week in the biotech sector with important regulatory ... Gilead Sciences, Inc. GILD stock tumbled after the Wall Street Journal reported that The Health and Human Services Department ...

Shares of clinical-stage biotech Chimerix skyrocketed following ... Moderna’s CEO Stephane Bancel and director Paul Sagan acquired common stock worth $6 million. MRNA also secured a legal ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...